chr12-753986-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_213655.5(WNK1):​c.421G>A​(p.Ala141Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,591,360 control chromosomes in the GnomAD database, including 12,812 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A141V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.099 ( 970 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11842 hom. )

Consequence

WNK1
NM_213655.5 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.186

Publications

26 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025852323).
BP6
Variant 12-753986-G-A is Benign according to our data. Variant chr12-753986-G-A is described in ClinVar as Benign. ClinVar VariationId is 137927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.421G>A p.Ala141Thr missense_variant Exon 1 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.0987
AC:
15015
AN:
152132
Hom.:
970
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0304
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.0725
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.0584
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.123
Gnomad OTH
AF:
0.0893
GnomAD2 exomes
AF:
0.123
AC:
24434
AN:
199102
AF XY:
0.130
show subpopulations
Gnomad AFR exome
AF:
0.0274
Gnomad AMR exome
AF:
0.0544
Gnomad ASJ exome
AF:
0.117
Gnomad EAS exome
AF:
0.0672
Gnomad FIN exome
AF:
0.242
Gnomad NFE exome
AF:
0.131
Gnomad OTH exome
AF:
0.126
GnomAD4 exome
AF:
0.122
AC:
176098
AN:
1439110
Hom.:
11842
Cov.:
94
AF XY:
0.124
AC XY:
88734
AN XY:
714316
show subpopulations
African (AFR)
AF:
0.0264
AC:
871
AN:
32938
American (AMR)
AF:
0.0549
AC:
2238
AN:
40748
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
2926
AN:
25672
East Asian (EAS)
AF:
0.0475
AC:
1829
AN:
38516
South Asian (SAS)
AF:
0.159
AC:
13417
AN:
84276
European-Finnish (FIN)
AF:
0.230
AC:
11574
AN:
50290
Middle Eastern (MID)
AF:
0.170
AC:
963
AN:
5670
European-Non Finnish (NFE)
AF:
0.123
AC:
135048
AN:
1101514
Other (OTH)
AF:
0.122
AC:
7232
AN:
59486
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
10771
21542
32312
43083
53854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4854
9708
14562
19416
24270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0986
AC:
15015
AN:
152250
Hom.:
970
Cov.:
33
AF XY:
0.104
AC XY:
7727
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0304
AC:
1264
AN:
41548
American (AMR)
AF:
0.0724
AC:
1109
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
389
AN:
3468
East Asian (EAS)
AF:
0.0586
AC:
303
AN:
5174
South Asian (SAS)
AF:
0.147
AC:
710
AN:
4820
European-Finnish (FIN)
AF:
0.241
AC:
2560
AN:
10602
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.123
AC:
8348
AN:
68008
Other (OTH)
AF:
0.0879
AC:
186
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
699
1398
2097
2796
3495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.109
Hom.:
655
Bravo
AF:
0.0809
TwinsUK
AF:
0.124
AC:
460
ALSPAC
AF:
0.123
AC:
474
ESP6500AA
AF:
0.0255
AC:
107
ESP6500EA
AF:
0.108
AC:
896
ExAC
AF:
0.107
AC:
12721
Asia WGS
AF:
0.0920
AC:
321
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 07, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.086
T;.;T;.;.;T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.49
N
LIST_S2
Uncertain
0.94
D;D;D;D;D;D
MetaRNN
Benign
0.0026
T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.1
.;M;M;M;M;.
PhyloP100
0.19
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.5
N;N;N;.;N;N
REVEL
Benign
0.086
Sift
Uncertain
0.024
D;D;D;.;D;D
Sift4G
Benign
0.55
T;.;T;T;T;T
Polyphen
0.11
B;.;B;.;.;B
Vest4
0.20
MPC
0.71
ClinPred
0.012
T
GERP RS
4.3
Varity_R
0.073
gMVP
0.18
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11554421; hg19: chr12-863152; COSMIC: COSV60031163; API